ResourceLife Sciences
Biomarkers for liver disease: a quick overview
2 Mar 2023Liver disease refers to any damage or disorder that limits or reduces the function of the liver. Liver diseases account for approximately 2 million deaths worldwide, 1 million due to complications of cirrhosis and others due to viral hepatitis and hepatocellular carcinoma. In this eBook, learn about new therapies and biomarkers used to treat different types of liver disease. Discover the current treatments available for cirrhosis, nonalcoholic fatty liver disease, hepatitis, hepatocellular carcinoma, and more, including an insight into the ongoing research that is happening in this field.
Links
Tags
BiomarkersBiomarkers are biological markers which can be measured and evaluated to indicate a biological state. The use of biomarkers in research and diagnosis can indicate a normal or disease state or drug response of cells / tissues. Biomarkers include genetic markers, cell surface markers such as antigens, antibodies or receptors and secreted molecules such as cytokines. An assay system is required for identification of biomarkers. :HepatitisLiver DiseaseBiomarker DiscoveryClinical biomarkers refer to substances related to known medical conditions that can be accurately measured <i>in vitro</i>. Biomarkers can be used to diagnose presence of a disease and indicate disease severity. The discovery of new biomarkers is incredibly valuable in the field of diagnostics.